Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic which has induced …

Patients with haematological malignancies are at high risk of infection because of various
mechanisms of humoral and cell-mediated immune deficiencies, which mainly depend on …

Background Previous studies have shown that children and adolescents with COVID-19
generally have mild disease. Children and adolescents with cancer, however, can have …

The novel coronavirus disease 2019 (COVID-19) was first reported in China in December
2019. Since then, it has spread across the world to become one of the most serious life …

Survival rates for pediatric cancer have steadily improved over time but it remains a
significant cause of morbidity and mortality among children. Infections are a major …

In Deutschland leben aktuell circa 4 Mio. Menschen, die in ihrem Leben eine
Krebserkrankung diagnostiziert bekommen haben [171]. Im Zeitraum von 1980–2017 …

Leukostasis is a life-threatening complication of high concentrations of circulating leukemic
cells, most often myeloblasts. Effective care of patients with leukostasis involves early …

COVID-19 has a mild clinical course with low mortality rate in general pediatric population,
while variable outcomes have been described in children with cancer. Infectious diseases …

Background Patients with pediatric cancer have a higher risk of morbidity and mortality
because of respiratory viral infections than other patient populations. Objectives To …

Background: The role of respiratory viruses (RV) in children with cancer having febrile
neutropenic episodes has not been well studied. The objectives of our study were to …